| Application no. and date | 23188938.7 (espacenet) (Federated) (European Patent Register), 20161229 | | Patent/reg. no. and date | DK/EP 4285902, 20251119 | | Publication date | 20231206 | | Priority no. and date | US 201562272890 P, 20151230, US 201662300479 P, 20160226, US 201662315412 P, 20160330, US 201662402454 P, 20160930, US 201662428867 P, 20161201, US 201662431791 P, 20161208 | | EP pub. no. and date |
EP 4285902 20231206 | | Effective date | | | Applicant/owner | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | | Applicant ref. no. | 2042694 | | Inventor | DO, Hung V.,
Philadelphia, 19104, US,
KHANNA, Richie,
Philadelphia, 19104, US,
GOTSCHALL, Russell,
Philadelphia, 19104, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61K 38/47 (2006.01) , A61P 43/00 (2006.01) | | Title | FORSTÆRKET SYRE-ALFA-GLUCOSIDASE TIL BEHANDLING AF POMPES SYGDOM | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
